GVHD

Clinical trials for GVHD explained in plain language.

Never miss a new study

Get alerted when new GVHD trials appear

Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Terminated 1

Can patients safely stop Anti-Rejection drugs sooner after transplant?

Disease control Not yet recruiting

This study tests whether patients who receive a stem cell transplant for blood cancers can safely stop taking the immunosuppressive drug tacrolimus earlier than usual. About 50 participants will be enrolled to see if early cessation by day 88 is feasible and does not lead to seve…

Matched conditions: GVHD

Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control

Last updated Apr 28, 2026 13:02 UTC

GVHD

Get alerted when new GVHD trials appear

Can patients safely stop Anti-Rejection drugs sooner after transplant?